In India and México, cardiovascular diseases are the first cause of death and potential years of life lost. Close similarities exist between these two countries when facing the difficulties to establish a universal reperfusion program for ST elevation myocardial infarction (STEMI). This paper describes the situation of STEMI treatment in both countries, and examines the lessons that Mexico's health care system could adopt from the recent advances accomplished by the STEMI initiative in India.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.acmx.2017.10.006 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!